Advancing science, one collaboration at a time.
FOR
Qualified academic and institutional researchers investigating the therapeutic potential of mesenchymal stromal cells.
OFFERING
Sponsored supply of amniotic-fluid-derived MSCs (AF-MSCs) for ethically approved, non-clinical research programs.
RESEARCH PARTNERSHIP PROGRAM
OUR COMMITMENT TO SCIENCE
Every therapy that reaches a patient begins in a lab. We support the scientists whose discoveries precede ours - because advancing regenerative medicine is a collective undertaking, not a private race.
— THE ALVION BIO PHILOSOPHY
What we offer.
01 / MATERIAL
CELLULAR PROVISION
Direct sponsored access to our standardized, high-potency AF-MSCs, produced under rigorous quality control for consistency across research cohorts.
We provide the essential biological infrastructure and dedicated expertise required to transition regenerative concepts from early-phase discovery toward scalable therapeutic applications.
02 / SUPPORT
TECHNICAL GUIDANCE
Co-development of experimental protocols and optimization of culture conditions to ensure the best possible research outcomes using our platform cell lines.
03 / PARTNERSHIP
TRANSLATIONAL PATHWAY
Strategic collaboration framework for promising results, providing a clear route toward licensing, clinical trials, and industrial-scale manufacturing.
Who is eligible.
01
Principal Investigators at recognized academic institutions or non-profit research organizations.
02
Programs focusing on translational applications in oncology, immunology, or neurology.
03
The study must have reached at least the proof-of-concept stage with internal data.
04
Establishment of strict ethical clearance (IRB/REC) for the proposed non-clinical use.
05
Intent to publish results in peer-reviewed journals with proper material attribution.
Built on responsibility.
Ethical Sourcing
All amniotic fluid donations are obtained through voluntary, informed consent protocols approved by recognized Institutional Review Boards (IRB).
Full Traceability
Each cell batch is accompanied by comprehensive documentation, ensuring researchers can maintain audit-ready protocols for their programs.
We adhere to the highest international biosafety and ethical standards, ensuring that every cell line provided through our program is documented, traceable, and ethically sourced. Our commitment to transparency is the foundation of every partnership.
Regulatory Rigor
Our facilities and processes are designed to meet EU and international standards for cell-based research material and quality management.
Scientific Integrity
We prioritize methodological accuracy and peer-validated approaches to help our partners produce high-impact, replicable research.
FROM PROPOSAL TO PARTNERSHIP
A considered process.
01
02
03
04
Proposal Submission
Scientific Review
Onboarding & MTA
Material Transfer
Submit a concise research overview outlining your study objectives and material requirements through our portal.
Our board evaluates the scientific merit and alignment with our mission, ensuring the best use of our cell platforms.
Upon approval, we finalize a simple Material Transfer Agreement to protect intellectual property on both sides.
Standardized cellular material is shipped under controlled conditions, accompanied by validation protocols.
IMPORTANT NOTICE
The Research Partnership Program and the supply of amniotic-fluid-derived mesenchymal stromal cells (AF-MSCs) are provided strictly for non-clinical, ethically approved laboratory research purposes only. Alvion Bio AB makes no representations or warranties regarding the suitability of these materials for any specific experimental outcome. Participation in this program does not constitute a transfer of intellectual property rights unless explicitly defined in a separate executed agreement. Alvion Bio AB reserves the right to terminate supply at its sole discretion based on compliance review or material availability. Research partners are responsible for ensuring all local regulatory and institutional biosafety approvals are maintained throughout the duration of the partnership. Alvion Bio AB shall not be liable for any claims, losses, or damages arising from the storage, handling, or application of cellular materials provided under this program.